Market Analysts see CRISPR Therapeutics AG [CRSP] gaining to $99. Time to buy?
CRISPR Therapeutics AG [NASDAQ: CRSP] stock went on a downward path that fall over -11.86% on Tuesday, amounting to a one-week price decrease of less than -11.34%. Over the last 12 months, CRSP stock dropped by -39.79%. The one-year CRISPR Therapeutics AG stock forecast points